600866.SH
星湖科技
SSE · Healthcare · Biotechnology · CN
CNY 4.23
−0.47%Year over year
Reported trailing growth
- Revenue
- -9.2%
- EBITDA
- —
- EBIT
- -64.2%
- EPS
- -60.7%
- Free cash flow
- —
- Operating cash flow
- -94.9%
Forward estimates
Based on analyst estimates
- Revenue
- -70.0%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.1%
- EBITDA
- -5.3%
- EBIT
- -5.6%
- Net income
- +17.2%
- EPS
- +4.8%
- Free cash flow
- —
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026